Infections and antibiotic use during pregnancy linked to childhood asthma
Both maternal antibiotic use and infections during pregnancy are associated with childhood asthma at 7 years, according to a new MoBa study. But it is still important for pregnant women to take antibiotics when they have been told to do so by their doctor.
Around four per cent of seven-year-olds in Norway have asthma. It is established that antibiotic use during pregnancy has been linked to asthma in children, but it has been unclear whether it is antibiotics or the infections that is the main cause.
In this study, researchers from the Norwegian Institute of Public Health and the University of Oulu, Finland, set out to distinguish the effect of antibiotics from infections during pregnancy on childhood asthma.
The researchers analysed data from two population-based cohorts, including 53 417 children in the Norwegian Mother, Father and Child Cohort Study (MoBa), and 541 036 children in the Medical Birth Registry in Norway. Information about infections during pregnancy was available in the MoBa cohort but not in the register-based cohort.
Antibiotics associated with asthma
In both cohorts, maternal antibiotic use during pregnancy was associated with asthma at 7 years of age.
In the MoBa cohort, children of mothers who used two or more antibiotics during pregnancy had a 54 per cent increased risk of asthma at seven years of age compared to children of mothers who did not take antibiotics. They did not however find this trend in the register-based cohort.
The risk of asthma was higher if mothers took antibiotics in later stages of pregnancy (17 weeks or later) in the MoBa cohort, but not in the register-based cohort.
The main author of the study, Aino Rantala, explains:
“We found that in the MoBa cohort the association was dose-dependent, which means that the more antibiotics you take, the greater the risk. The risk also seems to increase with antibiotic use later in pregnancy. This may be because in later pregnancy, antibiotic use has the strongest influence on the infant’s microbiota, which is important in immune system development”.
The association between maternal antibiotic use and childhood asthma decreased when the researchers controlled for maternal infections during pregnancy. This indicates that maternal infections during pregnancy also play a role in the risk of asthma.
Maternal infections and asthma
- In the MoBa cohort, children of mothers who had two or more respiratory tract infections had 14 per cent higher risk of asthma at age 7 than children of mothers without these infections.
Interestingly in MoBa, children of mothers who had lower respiratory tract infections during pregnancy but who did not use antibiotics had a higher risk of asthma, compared to children of mothers who used antibiotics for specific infections.
Aino Rantala therefore emphasises the importance of only taking antibiotics when necessary.
“Since untreated infections during pregnancy may pose an even greater risk of asthma in children than simply taking antibiotics, it is advisable to take prescribed antibiotics that are known to be effective for specific infections. However, since using two or more antibiotics during pregnancy also increases risk of asthma, it is probably not wise to take antibiotics just in case. In other words, pregnant women should still use antibiotics, but only when necessary.”
About the study
The results from both cohorts differed somewhat, which might be due to the differences between the two population cohorts. The findings reported here were controlled for numerous exposures that could have had an effect, including maternal age, smoking during pregnancy, and mode of delivery, but there may be also other factors involved that they did not control, such as genetic or other environmental exposures.
The study was conducted by researchers at the Department of Chronic Diseases and the Centre for Fertility and Health at the NIPH, in collaboration with the Center for Environmental and Respiratory Health Research, University of Oulu, Finland. The study was financed by the European Respiratory Society and by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research.